Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
about
Calcium phosphate nanoparticles-based systems for siRNA deliveryCurrent and Future Theranostic Applications of the Lipid-Calcium-Phosphate Nanoparticle Platform.Strategies on the nuclear-targeted delivery of genessiRNA delivery to the lung: what's new?Lipid-based vectors for siRNA deliveryHow does the cell overcome LCP nanoparticle-induced calcium toxicity?Maximizing the Supported Bilayer Phenomenon: Liposomes Comprised Exclusively of PEGylated Phospholipids for Enhanced Systemic and Lymphatic Delivery.Triple-responsive expansile nanogel for tumor and mitochondria targeted photosensitizer delivery.Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate.Development of small RNA delivery systems for lung cancer therapy.Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancerEffect of surface properties on liposomal siRNA delivery.Targeted delivery of siRNA-generating DNA nanocassettes using multifunctional nanoparticles.Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cellsNanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis.Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.Nanoparticles containing insoluble drug for cancer therapy.Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.Lipid-enveloped hybrid nanoparticles for drug delivery.Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.Lipid-based nanoparticles in the systemic delivery of siRNA.Nanoparticle-mediated delivery of siRNA for effective lung cancer therapy.Nanocarriers for delivery of siRNA and co-delivery of siRNA and other therapeutic agents.Lung cancer nanomedicine: potentials and pitfalls.Recent advances in siRNA delivery.Recent developments in nanomedicine for melanoma treatment.Novel nanoparticulate systems for lung cancer therapy: an updated review.Inhibition of pulmonary cancer progression by epidermal growth factor receptor-targeted transfection with Bcl-2 and survivin siRNAs.Targeting Nanocarriers with Anisamide: Fact or Artifact?Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery.Applying nanotherapeutics to improve chemoradiotherapy treatment for cancer.Potent calcium phosphate nanoparticle surface coating for in vitro and in vivo siRNA delivery: a step toward multifunctional nanovectors
P2860
Q26744039-38A94C80-3D90-4A19-A021-73143F0FBD22Q26746186-1BC9D06C-E672-49D6-B541-D08C829528D9Q26852376-38755D68-A77F-475C-80B2-CADA5B9ED934Q27022043-7C0B15AD-CEA8-44F5-90B0-5E6A11E35CD2Q28828356-9404A23F-850F-4FD1-A8CD-A8AF48A577CFQ30573647-884250A9-6914-4748-BA91-C24B0BDC728DQ33908258-17504823-523D-49B6-8031-3325A7F3DAD1Q34146404-2F418E75-3E0F-424B-B323-26090070F20DQ34781094-A4BDF1DA-5D03-4C99-8088-BDFDBC77C078Q35380932-EEEAC48E-D906-4402-B09C-545FAEC1F3EDQ36356958-04297182-7805-456C-8726-365B7CFE7C1DQ36421379-CF0FD49E-50EF-491D-953D-941CFE06B912Q36906374-E949D1E5-EFA1-4A10-85F8-239898A3A3A7Q36907352-590A0EAC-7D0C-4C94-B2F5-1D7A1035D5F9Q37229892-F3B2E6E1-F2A8-48B5-BE9C-5DF19EB9A038Q37254863-4B9217F8-8122-43F0-B8B0-C2C4160FB3EAQ37476252-FD5D31D3-2AA1-457D-AEEA-A3DF0A708E7AQ37588032-121D6F1B-E592-42DE-BC35-AC8C3FD64E65Q37693046-28CC91F0-5B7F-405C-B064-3BD16FD9ABD2Q37731821-338AEDB0-1763-45A1-8AD1-AAC4CF220FBAQ38071910-D8F8B48F-2842-4A4A-A90B-028EFB20FF4DQ38074442-1B86F7C8-E711-47AA-BBF0-8D63CB771B2AQ38172634-58D79987-F579-47C4-A522-BE30B4486D60Q38451918-64423929-90D2-4B80-82D3-A8154E4439CBQ38555082-3294D931-2949-426A-B96E-B1E9BCBC118CQ38608622-F9B064D6-2688-4292-A29A-63F0E349AEC8Q38648525-472A6502-E830-4F9D-B396-1471EC84CD37Q38740124-E6C2279D-9DBD-4E53-ABCA-CCC6F13B7C30Q38762917-71FD2068-7BA6-4F93-87FC-31F8573129ACQ38889289-CDEC8A86-2E80-46D7-8F85-2A2BDD676479Q39019352-E33FBEF2-8C3A-4A40-B4AD-EDD12488DB7AQ43238303-7F7F7E74-8546-46B2-B048-D2E6705A46D4Q46261083-D6FDCCCB-074F-473A-9D15-E91AC69A63EAQ47274570-FB69DCFE-D223-4D39-A20D-F4C0B11FEC73Q50499549-065EA4D5-7716-40F7-9932-51F728A40DB5Q58002746-D566B594-33D5-41E3-B41A-FE54F04D7942
P2860
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
@ast
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
@en
type
label
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
@ast
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
@en
prefLabel
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
@ast
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis.
@en
P2093
P2860
P356
P1433
P1476
Systemic delivery of siRNA via LCP nanoparticle efficiently inhibits lung metastasis
@en
P2093
P2860
P304
P356
10.1038/MT.2011.270
P50
P577
2011-12-20T00:00:00Z